Wells Fargo & Company Bei Gene, Ltd. Transaction History

Wells Fargo & Company

  • $410 Billion
  • Q1 2024

A detailed history of Wells Fargo & Company transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Wells Fargo & Company holds 83,125 shares of BGNE stock, worth $13.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83,125
Previous 49,036 69.52%
Holding current value
$13.5 Million
Previous $8.84 Million 46.98%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$141.8 - $181.47 $4.83 Million - $6.19 Million
34,089 Added 69.52%
83,125 $13 Million
Q4 2023

Feb 09, 2024
SELL
$158.67 - $201.58 $309,723 - $393,484
-1,952 Reduced 3.83%
49,036 $8.84 Million
Q3 2023

Nov 13, 2023
SELL
$179.87 - $225.13 $1.53 Million - $1.92 Million
-8,525 Reduced 14.32%
50,988 $9.17 Million
Q2 2023

Aug 15, 2023
SELL
$178.3 - $266.78 $941,424 - $1.41 Million
-5,280 Reduced 8.15%
59,513 $10.6 Million
Q1 2023

May 12, 2023
BUY
$215.53 - $274.5 $608,010 - $774,364
2,821 Added 4.55%
64,793 $14 Million
Q4 2022

Feb 13, 2023
SELL
$125.51 - $229.3 $642,234 - $1.17 Million
-5,117 Reduced 7.63%
61,972 $13.6 Million
Q3 2022

Nov 14, 2022
SELL
$131.8 - $202.24 $303,535 - $465,758
-2,303 Reduced 3.32%
67,089 $9.04 Million
Q2 2022

Aug 12, 2022
SELL
$121.11 - $216.05 $219,935 - $392,346
-1,816 Reduced 2.55%
69,392 $11.2 Million
Q1 2022

May 16, 2022
BUY
$146.52 - $269.56 $2.4 Million - $4.41 Million
16,366 Added 29.84%
71,208 $13.4 Million
Q4 2021

Feb 14, 2022
SELL
$248.56 - $389.34 $491,651 - $770,114
-1,978 Reduced 3.48%
54,842 $14.9 Million
Q3 2021

Nov 15, 2021
SELL
$249.6 - $403.14 $117,811 - $190,282
-472 Reduced 0.82%
56,820 $20.6 Million
Q2 2021

Aug 16, 2021
SELL
$292.75 - $367.01 $5.27 Million - $6.61 Million
-18,016 Reduced 23.92%
57,292 $19.7 Million
Q1 2021

May 13, 2021
BUY
$260.64 - $382.12 $3.09 Million - $4.53 Million
11,866 Added 18.7%
75,308 $26.2 Million
Q4 2020

Feb 09, 2021
SELL
$221.31 - $316.61 $512,553 - $733,268
-2,316 Reduced 3.52%
63,442 $16.4 Million
Q3 2020

Nov 05, 2020
BUY
$189.18 - $286.44 $2.32 Million - $3.52 Million
12,288 Added 22.98%
65,758 $18.8 Million
Q2 2020

Aug 13, 2020
SELL
$123.9 - $195.41 $10,655 - $16,805
-86 Reduced 0.16%
53,470 $10.1 Million
Q1 2020

May 14, 2020
BUY
$121.84 - $173.19 $6.53 Million - $9.28 Million
53,556 New
53,556 $6.59 Million

Others Institutions Holding BGNE

# of Institutions
213
Shares Held
45.1M
Call Options Held
76.5K
Put Options Held
72.3K
View Full List

About BeiGene, Ltd.

BGNE Quotes by TradingView
  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $16.9B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email